PharmaCom BioVet, Inc. (PHMB) operates a network of specialized treatment centers across the United States, dedicated to veterinary oncology. The company's core mission involves advancing bone marrow transplantation and various other innovative cancer therapies for companion animals, particularly those diagnosed with lymphoma, other forms of cancer, and presently incurable conditions. To mitigate suffering in animals battling cancer, PharmaCom BioVet has secured licenses for proprietary medical devices and pharmaceutical compounds.